Tag: stock exchange

The microgrid, which will feature a floating PV array and lithium-ion batteries in addition to Quino’s technology, will dramatically decrease Himandhoo Island’s reliance on imported diesel fuel

The microgrid, which will feature a floating PV array and lithium-ion batteries in addition to Quino’s technology, will dramatically decrease Himandhoo Island’s reliance on imported diesel fuel

Louvain-La-Neuve, Belgium, June 25, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract with the Fundação Severino Sombra (FUSVE), a non-profit philanthropic healthcare and educational institution responsible for the University of Vassouras and Hospital Mário Kroeff, for the purchase of a Proteus^®ONE¹ system.

— Registration-enabling study demonstrated high clinically meaningful objective responses, achieving rapid and durable disease control —

All amounts presented in this release are in U.S. Dollar (“USD”) unless otherwise stated.

The microgrid, which will feature a floating PV array and lithium-ion batteries in addition to Quino’s technology, will dramatically decrease Himandhoo Island’s reliance on imported diesel fuel

The microgrid, which will feature a floating PV array and lithium-ion batteries in addition to Quino’s technology, will dramatically decrease Himandhoo Island’s reliance on imported diesel fuel

NEW YORK and TORONTO, June 24, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), is pleased to announce the pricing of an underwritten offering of 10,309,280 common shares in the capital of the Company (the “Common Shares”) at an offering price of US$4.85 per Common Share, for aggregate gross proceeds of US$50 million (the “Offering”).